Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Children born to mothers on PrEP appeared to have normal growth and cognitive development.
New formulations and alternative injection sites could allow people to administer the shots at home.
Most people in a pilot program at a safety-net HIV clinic achieved viral suppression on the long-acting injectable regimen.
Apretude for HIV prevention is as effective for trans women as it is for gay men, with no adverse effects on hormone therapy.
Doxycycline post-exposure prophylaxis within three days after sex lowered the risk of gonorrhea, chlamydia and syphilis.
Stigma and systemic racism can kill, according to the first study to look at suicide risk among HIV-positive youth.
WHO offers the best ways to prevent, diagnose and treat HIV, hepatitis and sexually transmitted infections for five key populations.
A new case may provide clues to help researchers develop strategies for a functional cure.
Health researchers are testing the flying bots in remote rural regions and congested urban areas alike.
A new global alliance launches to end AIDS in children by 2030. Currently, only half of children with HIV are on lifesaving treatment.
New research looks at strategies to improve social connections for people living with HIV.
Activists at AIDS 2022 say monkeypox vaccines and treatment are not reaching the gay and bisexual men who need them most.
Public health programs are failing to provide adequate PrEP access for Black and Latino Americans.
Generic cabotegravir, an every-other-month injectable to prevent HIV, will arrive in select countries. WHO and Health Gap have opinions.
Without a major global effort, the world will miss HIV reduction targets, a new UNAIDS report warns.
While the risky procedure is not suitable for most people living with HIV, it offers clues for more feasible approaches.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.